Tag: Market access
Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s first annual Strategic Evidence & Value Communication Symposium. Across two panel discussions, a host of Certara and industry experts will debate and explore various best practices to ensure effective communication of product value, as well as the expanded use of Real World Evidence to accelerate market access decision-making.
The US reimbursement landscape for prescription drugs has been shifting rapidly over the last few years. Some of the major US access trends that have accelerated include: Payers increasing volume control over prescribed therapies, tightening formularies, and utilization management As the site-of-care landscape is consolidating, provider groups are incentivized to shift away from volume to … Continued
This blog discusses the challenges that drug developers face in getting patients access to cell and gene therapies as well as some potential solutions.
White Papers’ Findings Accepted for Poster Presentation at AMCP Nexus 2020 Meeting PRINCETON, N.J.—October 6, 2020. Certara, a global leader in biosimulation, today announced that its Evidence & Access group has published a series of four white papers on key trends poised to shape U.S. market access. The series titled “Disruptive Trends in U.S. Market … Continued